RNA aptamers in sepsis therapy
Aptamers are special nucleic acids with structural characteristics which allow them to bind to a specific protein as a target molecule. Selected RNA aptamers with a characteristic lead structure already exist, which bind specifically to the murine, lipopolysaccharide-binding protein (mLBP). This protein LBP plays a key role during septic shock and is linked to the LPS-induced signalling cascade. The selected RNA aptamers constitute valuable molecular tools in sepsis research and fulfil the preconditions for the development of new diagnostic and therapeutic medicines for the treatment of septic shock.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…
